Rachel King Net Worth & Insider Trades
Rachel King - Director, Novavax Inc
What is Rachel King's Net Worth?
The current estimated net worth of Novavax Inc's Director, Rachel King, is estimated to be about $1.04M . Rachel King owns about 3,900 units of Novavax Inc common stock. In the last 4 years at Novavax Inc, Rachel King has sold an estimated value of $0 worth.
What is Rachel King's Past Insider Trading?
Rachel King's largest purchase order was 700 units , worth over $97.75K on May 21, 2021. In total, Rachel King has made about 9 transactions over 4 years of their time at Novavax Inc. Rachel King usually trades in June, with the busiest year in 2021.
Rachel King
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Rachel King's' Mailing Address?
- Mailing address is C/o Glycomimetics, Inc. 401 Professional Drive, Suite 250 Gaithersburg MD 20879 MD
Novavax Inc Executive Compensation
Name |
Year
|
Salary
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|
| Stanley C. Erck Stanley C. Erck | 2020 | $657,181 | $48,086,018 | $44,115,244 | $48,086,018 | $11,400 | $48,086,018 |
| Stanley C. Erck Stanley C. Erck | 2019 | $642,720 | $2,438,562 | $986,660 | $2,438,562 | $11,200 | $2,438,562 |
| Stanley C. Erck Stanley C. Erck | 2018 | $638,040 | $4,158,398 | $3,509,358 | $4,158,398 | $11,000 | $4,158,398 |
| Gregory F. Covino | 2020 | $55,000 | $1,417,774 | $659,967 | $1,417,774 | $8,032 | $1,417,774 |
| Gregory F. Covino | 2019 | $― | $― | $― | $― | $― | $― |
| Gregory F. Covino | 2018 | $― | $― | $― | $― | $― | $― |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2020 | $483,443 | $24,923,376 | $22,859,741 | $24,923,376 | $11,400 | $24,923,376 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2019 | $470,453 | $1,875,198 | $819,421 | $1,875,198 | $11,200 | $1,875,198 |
| Gregory M. Glenn, M.D. Gregory M. Glenn, M.D. | 2018 | $460,125 | $1,681,456 | $1,131,189 | $1,681,456 | $11,000 | $1,681,456 |
| John J. Trizzino John J. Trizzino | 2020 | $415,892 | $21,327,954 | $19,819,717 | $21,327,954 | $11,400 | $21,327,954 |
| John J. Trizzino John J. Trizzino | 2019 | $390,701 | $1,465,602 | $584,103 | $1,465,602 | $9,546 | $1,465,602 |
| John J. Trizzino John J. Trizzino | 2018 | $378,078 | $1,329,776 | $890,700 | $1,329,776 | $7,500 | $1,329,776 |
| John A. Herrmann III John A. Herrmann III | 2020 | $402,842 | $20,606,814 | $18,924,907 | $20,606,814 | $11,400 | $20,606,814 |
| John A. Herrmann III John A. Herrmann III | 2019 | $378,591 | $1,353,416 | $488,397 | $1,353,416 | $11,200 | $1,353,416 |
| John A. Herrmann III John A. Herrmann III | 2018 | $362,695 | $1,137,576 | $712,560 | $1,137,576 | $11,000 | $1,137,576 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1000694/000110465921060332/tm212692d3_def14a.htm
What are Novavax Inc's Past Insider Trades?
Novavax Inc's most recent insider trade came on March 14, 2023 by Gregory Glenn who sold 2,432 units worth $15.86K . In the last 20 years, insiders at Novavax Inc have sold an estimated value of $287.04M and bought an estimated value of $38.33M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Gregory Glenn, President, John A. Herrmann III, EVP, and John A. Herrmann Iii Attorney-In-Fact, EVP .
NOVAVAX INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||